Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.03 $5.78 Monday, 13th May 2024 BCRX stock ended at $5.63. This is 5.83% more than the trading day before Friday, 10th May 2024. During the day the stock fluctuated 6.55% from a day low at $5.34 to a day high of $5.69.
90 days $4.03 $6.04
52 weeks $4.03 $8.96

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
Jul 08, 2016 $3.00 $3.12 $2.95 $3.09 488 800
Jul 07, 2016 $2.99 $3.03 $2.90 $2.99 279 700
Jul 06, 2016 $2.90 $3.03 $2.83 $2.99 290 500
Jul 05, 2016 $3.05 $3.17 $2.85 $2.93 515 500
Jul 01, 2016 $2.83 $2.98 $2.82 $2.94 330 300
Jun 30, 2016 $2.92 $2.94 $2.80 $2.84 408 800
Jun 29, 2016 $2.89 $2.94 $2.77 $2.91 481 700
Jun 28, 2016 $2.69 $2.86 $2.69 $2.81 569 700
Jun 27, 2016 $2.79 $2.82 $2.64 $2.66 673 300
Jun 24, 2016 $2.67 $2.86 $2.60 $2.84 802 300
Jun 23, 2016 $2.84 $2.94 $2.78 $2.94 371 600
Jun 22, 2016 $2.78 $2.89 $2.74 $2.81 386 100
Jun 21, 2016 $2.86 $2.86 $2.71 $2.77 386 700
Jun 20, 2016 $2.84 $2.92 $2.78 $2.85 338 800
Jun 17, 2016 $2.91 $2.91 $2.78 $2.80 866 600
Jun 16, 2016 $2.96 $2.96 $2.74 $2.88 872 452
Jun 15, 2016 $2.91 $3.04 $2.86 $2.99 742 429
Jun 14, 2016 $3.03 $3.06 $2.82 $2.91 595 415
Jun 13, 2016 $3.02 $3.14 $3.00 $3.05 999 801
Jun 10, 2016 $3.33 $3.35 $2.95 $3.05 1 603 535
Jun 09, 2016 $3.85 $3.87 $3.36 $3.38 1 299 045
Jun 08, 2016 $3.83 $3.94 $3.75 $3.88 702 424
Jun 07, 2016 $3.74 $4.03 $3.74 $3.83 1 344 984
Jun 06, 2016 $3.61 $3.83 $3.46 $3.77 833 531
Jun 03, 2016 $3.59 $3.70 $3.52 $3.60 826 687
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT